Quick Answer
Tyra Biosciences, Inc. reported Stockholders Equity of $259.18 million for fiscal year 2025.
Tyra Biosciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $259.18M | -24.5% |
| 2024 | $343.15M | +68.0% |
| 2023 | $204.26M | -20.8% |
| 2022 | $257.83M | -14.6% |
| 2021 | $301.74M | +2312.5% |
| 2020 | -$13.64M | -187.7% |
| 2019 | -$4.74M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $280.51M | -22.6% | -7.2% |
| June 30, 2025 | $302.15M | -19.7% | -6.6% |
| March 31, 2025 | $323.53M | -17.0% | -5.7% |
| December 31, 2024 | $343.15M | +68.0% | -5.3% |
| September 30, 2024 | $362.29M | +63.1% | -3.7% |
| June 30, 2024 | $376.04M | +57.6% | -3.5% |
| March 31, 2024 | $389.88M | +56.7% | +90.9% |
| December 31, 2023 | $204.26M | -20.8% | -8.1% |
- Tyra Biosciences, Inc. showed a decrease of -24.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Tyra Biosciences, Inc.’s stockholders equity has grown by 5566.7% (from -$4.74 million to $259.18 million).
- The most recent figure is from Tyra Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: